Some studies of nature and clinical significance of porphobilinogen.
作者信息
WATSON C J
出版信息
AMA Arch Intern Med. 1954 May;93(5):643-57. doi: 10.1001/archinte.1954.00240290001001.
Abstract
摘要
相似文献
1
Some studies of nature and clinical significance of porphobilinogen.
AMA Arch Intern Med. 1954 May;93(5):643-57. doi: 10.1001/archinte.1954.00240290001001.
2
Quantitative determination of free uroporphyrin, uroporphyrin zinc complex salt and porphobilinogen in urine porphyria.
Z Gesamte Inn Med. 1952 Dec 1;7(23):1086-90.
3
4
Renal clearance of endogenous porphobilinogen in man.
Lancet. 1954 Nov 27;267(6848):1095-7. doi: 10.1016/s0140-6736(54)90653-4.
5
Excretion of porphobilinogen and Delta-aminolaevulinic acid in acute porphyria.
Lancet. 1961 Aug 26;2(7200):485-6. doi: 10.1016/s0140-6736(61)92451-5.
6
Porphobilinogen and delta-amino levulinic acid in acute porphyria.
Proc Soc Exp Biol Med. 1955 Feb;88(2):270-3. doi: 10.3181/00379727-88-21560.
7
Isolation of porphobilinogen from the urine of a patient with acute porphyria.
Nature. 1952 Oct 11;170(4328):614-6. doi: 10.1038/170614a0.
8
Porphobilinogen; chemical constitution.
Nature. 1953 May 16;171(4359):875-6. doi: 10.1038/171875a0.
9
Best practice guidelines on first-line laboratory testing for porphyria.
Ann Clin Biochem. 2017 Mar;54(2):188-198. doi: 10.1177/0004563216667965. Epub 2017 Jan 19.
10
[On the excretion of 5-aminolevulinic acid and porphobilinogen in latent porphyria].
Folia Haematol Int Mag Klin Morphol Blutforsch. 1961;78:205-13.
引用本文的文献
1
[Porphyria cutanea tarda. II. The urine syndrome. Methods of investigation, findings, experimental studies].
Arch Klin Exp Dermatol. 1959;209:466-519.
2
[Light dermatoses and porphyrin photosensitization].
Arch Klin Exp Dermatol. 1960;210:496-522.
3
[Pseudopositive Watson-Schwartz test with tryptophan].
Klin Wochenschr. 1968 Feb 15;46(4):210-1. doi: 10.1007/BF01746238.
Zotero 插件